Harmony Biosciences is trading 4.06% up now at $40.98, despite broad market weakness and a 4.24% decline in biotechnology stocks.
- No clear company-specific announcement, earnings release, analyst action, or regulatory catalyst was identified for September 1, 2026.
- The latest notable update was an August 27 conference participation announcement, which appears too dated to explain the move; coverage also describes no significant recent news.